Average Co-Inventor Count = 4.36
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Exelixis, Inc. (2 from 175 patents)
2 patents:
1. 11198731 - Combinations of cabozantinib and atezolizumab to treat cancer
2. 11141413 - Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate